Effects of luteal phase support comparing early (day 1) and late (day 4) initiation with pregnancy rates;Effektiver beginn der lutealunterstützung analyse der schwangerschaftsraten bei frühem (tag 1) und spätem (tag 4) behandlungsbeginn

Journal fur Reproduktionsmedizin und Endokrinologie

Volumn 8, Issue 4, 2011, Pages 288-290

  Feichtinger, M ^a   Hajek, J ^a   Kemeter, P ^a   Feichtinger, W ^a  

^a Wunschbaby Zentrum   (Austria)

Author keywords

Estrogen; Gonadotropin releasing hormone agonists and antagonists; In vitro fertilization; Luteal phase support; Pregnancy rates; Progesterone

Indexed keywords

DYDROGESTERONE; ESTRADIOL VALERATE; PROGESTERONE;

ABORTION; ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILIZATION; HUMAN; IN VITRO STUDY; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 82755170262     PISSN: 18102107     EISSN: 18109292     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hubayter ZR, Suheil JM. Luteal supplementation in in vitro fertilization: more questions than answers. Fertil Steril 2008; 89: 749-58.
2. Adams C, Anderson L, Wheeler L, Wood S. Early administration of additional vaginal progesterone support has a detrimental effect on implantation rates in embryo recipient cycles. Fertil Steril 2007; 88: S24.
3. Sohn SH, Penzias AS, Emmi AM, Dubey AK, Layman LC, Reindollar RH et al. Administration of progesterone before oo-cyte retrieval negatively affects the implantation rate. Fertil Steril 1999; 71: 11-4.
4. Baruffi R, Mauri AL, Petersen CG, Felipe V, Franco JG Jr. Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates. J Assist Reprod Genet 2003; 20: 517-20.
5. Mochtar MH, Van Wely M, Van der Veen F. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles. Hum Reprod 2006; 21: 905-8.
6. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001 14; 357: 1191-4.
7. Gelbaya TA, Kyrgiou M, Tsoumpou I, Nardo LG. The use of estradiol for luteal phase support in in vitro fertilization/intra-cytoplasmic sperm injection cycles: a systematic review and meta-analysis. Fertil Steril 2008; 90: 2116-25.
8. Daya S. Luteal support: progestogens for pregnancy protection. Maturitas 2009; 65 (Suppl 1): S29-S34.
9. Tonguc E, Var T, Ozyer S, Citil A, Dogan M. Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomised study. Eur J Obstet Gynecol Reprod Biol 2011; 154: 172-6.
10. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068-76.
11. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002; 17: 2287-99.
12. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88: 4186-92.
13. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertil Steril 2006; 86: 92-7.
14. Williams SC, Oehninger S, Gibbons WE, Van Cleave WC, Muasher SJ. Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study. Fertil Steril 2001; 76: 1140-3.
15. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly Lower Pregnancy Rates in the Presence of Progesterone Elevation in Patients Treated with GnRH Antagonists and Gonadotrophins: A Systematic Review and Meta-Analy-sis. Curr Pharm Biotechnol 2011 [Epub ahead of print].
16. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 2003; 79: 873-80.
17. Chang SY, Soong YK, Chang M Y, Hsiu DY. Immediate versus delayed progesterone supplementation in gamete intra-fallopian transfer (GIFT). J In Vitro Fert Embryo Transf 1989; 6: 275-9.
18. Friedler S, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14: 1944-8.
19. Licciardi FL, Kwiatkowski A, Noyes NL, Berkeley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril 1999; 71: 614-8.
20. Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P. Progesterone for the luteal support of assisted reproductive technologies: clinical options. Hum Reprod 2000; 15 (Suppl 1): 129-48.